- call +1-201-465-4211
- email sales@mrinsights.biz
Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological product.
Scope of the Report:
The global Biosimilar of Remicade market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biosimilar of Remicade.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Biosimilar of Remicade market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biosimilar of Remicade market by product type and applications/end industries.
Market Segment by Companies, this report covers
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
100mg/10ml
500mg/50ml
Market Segment by Applications, can be divided into
Blood Disorders
Oncology Diseases
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Biosimilar of Remicade Market Overview
1.1 Product Overview and Scope of Biosimilar of Remicade
1.2 Classification of Biosimilar of Remicade by Types
1.2.1 Global Biosimilar of Remicade Revenue Comparison by Types (2017-2023)
1.2.2 Global Biosimilar of Remicade Revenue Market Share by Types in 2017
1.2.3 100mg/10ml
1.2.4 500mg/50ml
1.3 Global Biosimilar of Remicade Market by Application
1.3.1 Global Biosimilar of Remicade Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Blood Disorders
1.3.3 Oncology Diseases
1.4 Global Biosimilar of Remicade Market by Regions
1.4.1 Global Biosimilar of Remicade Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Biosimilar of Remicade Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Biosimilar of Remicade Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biosimilar of Remicade Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Biosimilar of Remicade Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biosimilar of Remicade Status and Prospect (2013-2023)
1.5 Global Market Size of Biosimilar of Remicade (2013-2023)
2 Manufacturers Profiles
2.1 Synthon Pharmaceuticals
2.1.1 Business Overview
2.1.2 Biosimilar of Remicade Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Synthon Pharmaceuticals Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
2.2 LG Life Sciences
2.2.1 Business Overview
2.2.2 Biosimilar of Remicade Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 LG Life Sciences Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis (Sandoz)
2.3.1 Business Overview
2.3.2 Biosimilar of Remicade Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis (Sandoz) Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
2.4 Celltrion
2.4.1 Business Overview
2.4.2 Biosimilar of Remicade Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Celltrion Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
2.5 Biocon
2.5.1 Business Overview
2.5.2 Biosimilar of Remicade Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Biocon Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
2.6 Hospira
2.6.1 Business Overview
2.6.2 Biosimilar of Remicade Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Hospira Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck Serono (Merck Group)
2.7.1 Business Overview
2.7.2 Biosimilar of Remicade Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Serono (Merck Group) Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
2.8 Biogen idec Inc.
2.8.1 Business Overview
2.8.2 Biosimilar of Remicade Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Biogen idec Inc. Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
2.9 Genentech (Roche Group)
2.9.1 Business Overview
2.9.2 Biosimilar of Remicade Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Genentech (Roche Group) Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
3 Global Biosimilar of Remicade Market Competition, by Players
3.1 Global Biosimilar of Remicade Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Biosimilar of Remicade Players Market Share
3.2.2 Top 10 Biosimilar of Remicade Players Market Share
3.3 Market Competition Trend
4 Global Biosimilar of Remicade Market Size by Regions
4.1 Global Biosimilar of Remicade Revenue and Market Share by Regions
4.2 North America Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
4.3 Europe Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
4.5 South America Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
5 North America Biosimilar of Remicade Revenue by Countries
5.1 North America Biosimilar of Remicade Revenue by Countries (2013-2018)
5.2 USA Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
5.3 Canada Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
5.4 Mexico Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
6 Europe Biosimilar of Remicade Revenue by Countries
6.1 Europe Biosimilar of Remicade Revenue by Countries (2013-2018)
6.2 Germany Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
6.3 UK Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
6.4 France Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
6.5 Russia Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
6.6 Italy Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Biosimilar of Remicade Revenue by Countries
7.1 Asia-Pacific Biosimilar of Remicade Revenue by Countries (2013-2018)
7.2 China Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
7.3 Japan Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
7.4 Korea Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
7.5 India Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
8 South America Biosimilar of Remicade Revenue by Countries
8.1 South America Biosimilar of Remicade Revenue by Countries (2013-2018)
8.2 Brazil Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
8.3 Argentina Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
8.4 Colombia Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Biosimilar of Remicade by Countries
9.1 Middle East and Africa Biosimilar of Remicade Revenue by Countries (2013-2018)
9.2 Saudi Arabia Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
9.3 UAE Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
9.4 Egypt Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
9.5 Nigeria Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
9.6 South Africa Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
10 Global Biosimilar of Remicade Market Segment by Type
10.1 Global Biosimilar of Remicade Revenue and Market Share by Type (2013-2018)
10.2 Global Biosimilar of Remicade Market Forecast by Type (2018-2023)
10.3 100mg/10ml Revenue Growth Rate (2013-2023)
10.4 500mg/50ml Revenue Growth Rate (2013-2023)
11 Global Biosimilar of Remicade Market Segment by Application
11.1 Global Biosimilar of Remicade Revenue Market Share by Application (2013-2018)
11.2 Biosimilar of Remicade Market Forecast by Application (2018-2023)
11.3 Blood Disorders Revenue Growth (2013-2018)
11.4 Oncology Diseases Revenue Growth (2013-2018)
12 Global Biosimilar of Remicade Market Size Forecast (2018-2023)
12.1 Global Biosimilar of Remicade Market Size Forecast (2018-2023)
12.2 Global Biosimilar of Remicade Market Forecast by Regions (2018-2023)
12.3 North America Biosimilar of Remicade Revenue Market Forecast (2018-2023)
12.4 Europe Biosimilar of Remicade Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Biosimilar of Remicade Revenue Market Forecast (2018-2023)
12.6 South America Biosimilar of Remicade Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Biosimilar of Remicade Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Biosimilar of Remicade Picture
Table Product Specifications of Biosimilar of Remicade
Table Global Biosimilar of Remicade and Revenue (Million USD) Market Split by P
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
